Edgar Wachenheim III
Greenhaven Associates
Edgar Wachenheim III Morgan Stanley stake
total: 102
Greenhaven Associates MS trades
- Total transactions:
- 11
- New positions:
- 2
- Sold out:
- 2
- Added:
- 2
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 22 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Edgar Wachenheim III doesn't hold any Morgan Stanley (MS) shares. To date, the estimated cost basis is nearly $44.74 for "buy" trades and estimated average "sell" price is $85.17. Greenhaven Associates first purchased MS in 2019 Q3, initially acquiring 273,500 shares. Edgar Wachenheim III later completely sold out the position and invested in Morgan Stanley again in 2020 Q1. Since the initial investment in Morgan Stanley (MS), Greenhaven Associates has made 10 more transactions.
When did Edgar Wachenheim III sell Morgan Stanley (MS)?
Edgar Wachenheim III sold off the entire Morgan Stanley (MS) position in 2025 Q3.
When did Edgar Wachenheim III buy Morgan Stanley (MS)?
Edgar Wachenheim III first invested in Morgan Stanley (MS) in 2019 Q3 at the reported quarter-end price of $42.67 per share.
What's the cost basis of Greenhaven Associates's MS stake?
The estimated cost basis for Morgan Stanley (MS) stake is around $44.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $44.74
- Weighted AVG sell price:
- $85.17
Edgar Wachenheim III's historical trades in Morgan Stanley
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$140.86
|
|
-100% (-10,000)
|
-0.02%
|
|
2021 Q4
|
0.02%
|
10,000
|
$98.20
|
$982,000
|
-96.26% (-257,090)
|
-0.84%
|
|
2021 Q3
|
0.87%
|
267,090
|
$97.31
|
$25,991,000
|
-3.33% (-9,200)
|
-0.03%
|
|
2021 Q2
|
0.74%
|
276,290
|
$91.69
|
$25,333,000
|
-95.15% (-5,417,974)
|
-11.23%
|
|
2021 Q1
|
9.99%
|
5,694,264
|
$77.66
|
$442,217,000
|
-40.32% (-3,846,281)
|
-5.62%
|
|
2020 Q4
|
12.31%
|
$68.53
|
+3.59% (+330,771)
|
|||
|
2020 Q3
|
9.78%
|
$48.35
|
-3.00% (-285,100)
|
|||
|
2020 Q2
|
10.15%
|
$48.30
|
+225.71% (+6,579,774)
|
|||
|
2020 Q1
|
3.69%
|
$34.00
|
new
|
|||
|
2019 Q4
|
0.00%
|
$42.67
|
-100% (-273,500)
|
|||
|
2019 Q3
|
0.24%
|
$42.67
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.